<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="glut1" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">glut1</book-part-id>
      <title-group>
        <title>Glucose Transporter Type 1 Deficiency Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonyms: De Vivo Disease, Glucose Transporter Protein Syndrome, Glut-1 Deficiency Syndrome, Glut1-DS</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Dong</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Neurology<break/>Southern Regional Medical Center<break/>Emory University Affiliated Hospital<break/>Riverdale, Georgia</aff>
          <email>dwang666888@gmail.com</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Pascual</surname>
            <given-names>Juan M</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Rare Brain Disorders Program<break/>University of Texas Southwestern Medical Center<break/>Dallas, Texas</aff>
          <email>juan.pascual@utsouthwestern.edu</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>De Vivo</surname>
            <given-names>Darryl</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Division of Pediatric Neurology<break/>Columbia University<break/>Neurological Institute of New York<break/>New York, New York</aff>
          <email>dcd1@columbia.edu</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>30</day>
          <month>7</month>
          <year>2002</year>
        </date>
        <date date-type="updated">
          <day>22</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>9</day>
          <month>9</month>
          <year>2008</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="gan" document-type="chapter">Giant Axonal Neuropathy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="nkh" document-type="chapter">Glycine Encephalopathy</related-object>
      <abstract id="glut1.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1-DS) is now known to be a continuum that includes the classic phenotype as well as dystonia 9, dystonia 18, atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal non-epileptic findings such as intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. The classic phenotype is characterized by infantile-onset seizures, delayed neurologic development, acquired microcephaly, and complex movement disorders. Seizures begin before age two years in approximately 90% and later in approximately 10%. Several seizure types occur: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified. The frequency, severity, and type of seizures vary among affected individuals and are not related to disease severity. Cognitive impairment, ranging from learning disabilities to severe intellectual disability, is typical. The complex movement disorder, characterized by ataxia, dystonia, and chorea, may occur in any combination and may be continuous, paroxysmal, or continuous with fluctuations in severity influenced by environmental factors such as fasting, fever, and intercurrent infection. Symptoms often improve substantially when a ketogenic diet is started.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis is established in neurologically affected individuals who have a low-normal or low CSF lactate concentration, normal blood glucose concentration, and low CSF glucose concentration (&#x0003c;60 mg/dL in all cases reported to date; &#x0003c;40 mg/dL in &#x0003e;90%; 41-52 mg/dL in ~10%). Detection of a heterozygous pathogenic variant (or rarely, biallelic pathogenic variants) in <italic toggle="yes">SLC2A1</italic> confirms the diagnosis. If no pathogenic variant is identified, 3-O-methyl-D-glucose uptake in erythrocytes can be performed; results between 35% and 74% of controls are diagnostic.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> The ketogenic diet is highly effective in mitigating clinical findings (i.e., controlling the seizures and improving the movement disorder and alertness). Ketone bodies use a different transporter to cross the blood-brain barrier and thus provide the brain with the only known alternative fuel for metabolism. The ketogenic diet is generally well-tolerated particularly if the family is properly instructed in the basic dietary principles at the beginning. Prognosis is improved if the ketogenic diet is started early in childhood. The ketogenic diet is deficient in L-carnitine and several vitamins necessitating daily supplementation. Affected individuals also develop a mild compensated metabolic acidosis when ketotic.</p>
          <p><italic toggle="yes">Prevention of primary manifestations:</italic> Early initiation of the ketogenic diet, ideally in infancy, results in better seizure control and improves long-term neurologic outcome.</p>
          <p><italic toggle="yes">Prevention of secondary complications:</italic> For those on a ketogenic diet: L-carnitine supplementation; proper hydration and avoidance of carbonic anhydrase inhibitors; avoidance of carbohydrate-containing foods, intravenous fluids, and medications that interrupt the state of ketosis; valproic acid.</p>
          <p><italic toggle="yes">Surveillance:</italic> Periodic measurement of blood ketone concentration with a target beta-hydroxybutyrate concentration of 3-5 mmol/L.</p>
          <p><italic toggle="yes">Agents to avoid:</italic> Barbiturates (e.g., phenobarbital, the most commonly used AED in infants), methylxanthines (e.g., caffeine), valproic acid.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> If the pathogenic variant has been identified in an affected family member, it is appropriate to test at-risk newborns and infants so that morbidity can be reduced by early diagnosis and treatment.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Most commonly Glut1-DS is inherited in an autosomal dominant (AD) manner. About 90% of individuals with AD Glut1-DS have the disorder as the result of a <italic toggle="yes">de novo</italic> heterozygous pathogenic variant; about 10% have a clinically affected parent. Parents who are heterozygous for the pathogenic variant may have a mild phenotype or be asymptomatic, findings that can suggest mosaicism in the parent. Offspring of an individual with AD Glut1-DS have a 50% chance of inheriting the pathogenic variant and being clinically affected. Rarely, Glut1-DS is inherited in an autosomal recessive (AR) manner. Carriers in families with AR Glut1-DS are asymptomatic. Prenatal testing for pregnancies at increased risk is possible if the pathogenic variant has been identified in families with AD inheritance or both pathogenic variants have been identified in families with AR inheritance.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="glut1.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="glut1.Tc" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_glut1.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Glucose Transporter Type 1 Deficiency Syndrome: Included Phenotypes</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_glut1.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Dystonia 9 (DYT9)</p></list-item><list-item><p>Dystonia 18 (DYT18)</p></list-item></list>
</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>For synonyms and outdated names see <xref ref-type="sec" rid="glut1.Nomenclature">Nomenclature</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="glut1.Diagnosis">
        <title>Diagnosis</title>
        <sec id="glut1.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Glucose transporter type 1 deficiency syndrome (Glut1-DS) usually presents in one of two ways:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Classic Glut1 DS (~90% of affected individuals).</bold> Seizures (onset between ages 1 and 6 months in ~70%, before age 2 years in ~90%, and after age 2 years in ~10%); delayed neurologic development, dysarthria , acquired microcephaly and complex movement disorders including ataxia, dystonia and chorea</p>
            </list-item>
            <list-item>
              <p><bold>Non-epileptic Glut1 DS (~10% of affected individuals).</bold> No clinical seizures and a milder phenotype, often demonstrating paroxysmal dyskinesias including intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia</p>
            </list-item>
          </list>
        </sec>
        <sec id="glut1.Testing">
          <title>Testing</title>
          <p><bold>CSF glucose concentration.</bold> The single most important laboratory observation in Glut1-DS is hypoglycorrhachia (reduced cerebrospinal fluid (CSF) glucose concentration). Following a four-hour fast, a blood sample is obtained just before performing the lumbar puncture.</p>
          <list list-type="bullet">
            <list-item>
              <p>The blood glucose concentration should be normal, ruling out hypoglycemia as the cause of the hypoglycorrhachia.</p>
            </list-item>
            <list-item>
              <p>The CSF/blood glucose ratio usually is less than 0.4 (range 0.19 to 0.59) in persons with Glut1-DS; however, this value is less reliable than the absolute CSF glucose value.</p>
            </list-item>
            <list-item>
              <p>All affected individuals reported to date have had CSF glucose values below 60 mg/dL (range: 16.2 to 52 mg/dL); in more than 90% it is below 40 mg/dL and in approximately 10% it is 41-52 mg/dL [<xref ref-type="bibr" rid="glut1.REF.de_vivo.2008.877">De Vivo &#x00026; Wang 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>, <xref ref-type="bibr" rid="glut1.REF.leen.2013.1440">Leen et al 2013</xref>].</p>
            </list-item>
          </list>
          <p><bold>CSF lactate concentration</bold> is low-normal or low, often below 1.3 mmol/L or 11.7 mg/dl (range from 5.4 to 13.5 mg/dL) [<xref ref-type="bibr" rid="glut1.REF.de_vivo.1991.703">De Vivo et al 1991</xref>, <xref ref-type="bibr" rid="glut1.REF.wang.2005.111">Wang et al 2005</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>, <xref ref-type="bibr" rid="glut1.REF.leen.2013.1440">Leen et al 2013</xref>].</p>
          <p><bold>Erythrocyte 3-O-methyl-D-glucose</bold>
<bold>uptake assay.</bold> The uptake assay is a functional measure of glucose transport across the cell membrane. Individuals with Glut1-DS have abnormal values that range from 35% to 74% of controls, with an average reduction of approximately 50% [<xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]. As such, it is abnormally low in almost all suspected cases.</p>
          <list list-type="bullet">
            <list-item>
              <p>Decreased 3-O-methyl-D-glucose uptake in erythrocytes confirms the diagnosis of Glut1-DS.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing detects a pathogenic variant in 95% of persons with abnormally low uptake assay.</p>
            </list-item>
            <list-item>
              <p>Of note, 3% of persons with Glut1-DS have a normal uptake assay, a finding that correlates with the presence of an <italic toggle="yes">SLC2A1</italic> pathogenic missense variant (see <xref ref-type="sec" rid="glut1.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
              <p>Note: The 3-O-methyl-D-glucose uptake assay is currently viewed as the diagnostic gold standard for this disease [<xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]; however, such testing may not be available on a clinical basis.</p>
            </list-item>
          </list>
          <p><bold>Positron emission tomography (PET).</bold> Cerebral fluoro-deoxy-glucose PET findings are distinctive with diffuse hypometabolism of the cerebral cortex and regional hypometabolism of the cerebellum and thalamus. Basal ganglia metabolism appears relatively preserved. This distinctive PET signature appears in early infancy and persists into adulthood regardless of disease severity or therapy with a ketogenic diet [<xref ref-type="bibr" rid="glut1.REF.pascual.2002.458">Pascual et al 2002</xref>]. The sensitivity and specificity of PET in the diagnosis of Glut1-DS have not been established.</p>
          <sec id="glut1.Molecular_Genetic_Testing">
            <title>Molecular Genetic Testing</title>
            <p><bold>Gene.</bold>
<italic toggle="yes">SLC2A1</italic> is the only gene in which pathogenic variants are known to cause glucose transporter type I deficiency syndrome (Glut1-DS).</p>
            <table-wrap id="glut1.T.summary_of_molecular_genetic_tes" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Summary of Molecular Genetic Testing Used in Glut1-DS</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">SLC2A1</italic>
                    </td>
                    <td headers="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2,&#x000a0;3</sup></td>
                    <td headers="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">48/54 (89%)&#x000a0;<sup>4</sup><break/>60/74 (81%)&#x000a0;<sup>5</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>6</sup></td>
                    <td headers="hd_h_glut1.T.summary_of_molecular_genetic_tes_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">6/54(11%)&#x000a0;<sup>4</sup><break/>10/74(14%)&#x000a0;<sup>5</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="glut1.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="glut1" object-id="glut1.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="glut1.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="glut1.TF.1.2">
                  <label>2. </label>
                  <p>Including the promoter and exons of <italic toggle="yes">SLC2A1</italic> [<xref ref-type="bibr" rid="glut1.REF.wang.2005.111">Wang et al 2005</xref>]</p>
                </fn>
                <fn id="glut1.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="glut1.TF.1.4">
                  <label>4. </label>
                  <p>48 (89%) of 54 probands with an <italic toggle="yes">SCL2A1</italic> pathogenic variant, 6 (11%) of 54 with (multi)exon or whole-gene deletions [<xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>]</p>
                </fn>
                <fn id="glut1.TF.1.5">
                  <label>5. </label>
                  <p>60 (81%) of 74 probands with an <italic toggle="yes">SCL2A1</italic> pathogenic variant, 10 (14%) of 74 with (multi)exon or whole-gene deletions [<xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]</p>
                </fn>
                <fn id="glut1.TF.1.6">
                  <label>6. </label>
                  <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
        <sec id="glut1.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To establish the diagnosis in a proband</bold> with clinical findings suggestive of Glut1-DS:</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Measure CSF and blood glucose concentrations following a four-hour fast.</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>In those with normal blood glucose concentration and CSF glucose concentration lower than 60 mg/dL, perform molecular genetic testing of <italic toggle="yes">SLC2A1.</italic></p>
            </list-item>
          </list>
          <p><bold>One genetic testing strategy</bold> is single-gene molecular genetic testing of <italic toggle="yes">SLC2A1</italic>.</p>
          <list list-type="order">
            <list-item>
              <label>1</label>
              <p>Sequence analysis is performed first.</p>
            </list-item>
            <list-item>
              <label>2</label>
              <p>If no pathogenic variant is identified through sequence analysis, deletion/duplication analysis may be considered.</p>
            </list-item>
          </list>
          <p><bold>An alternative genetic testing strategy</bold> is use of a multi-gene panel that includes <italic toggle="yes">SLC2A1</italic> and other genes of interest (see <xref ref-type="sec" rid="glut1.Differential_Diagnosis">Differential Diagnosis</xref>). Note: The genes included and the methods used in multi-gene panels vary by laboratory and over time.</p>
          <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of Glut1-DS. For issues to consider in interpretation of genomic test results, click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix">here</related-object>.</p>
          <p><bold>If molecular genetic testing fails to detect a pathogenic <italic toggle="yes">SLC2A1</italic> variant,</bold> consider performing erythrocyte glucose uptake assay (when feasible).</p>
        </sec>
      </sec>
      <sec id="glut1.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="glut1.Clinical_Description">
          <title>Clinical Description</title>
          <p>Glucose transporter type 1 deficiency syndrome (Glut1-DS) usually presents as either classic Glut1-DS (~90% of affected individuals) or non-epileptic Glut1-DS (~10% of affected individuals).</p>
          <p>Infants with the <bold>classic phenotype</bold> appear normal at birth following an uneventful pregnancy and delivery. Birth weight and Apgar scores are normal. They commonly experience infantile-onset epileptic encephalopathy refractory to anticonvulsants and associated with delayed neurologic development; later deceleration of head growth and acquired microcephaly; and ataxia, dystonia, and spasticity [<xref ref-type="bibr" rid="glut1.REF.klepper.1999b.116">Klepper et al 1999b</xref>, <xref ref-type="bibr" rid="glut1.REF.de_vivo.a">De Vivo et al 2002a</xref>, <xref ref-type="bibr" rid="glut1.REF.de_vivo.2002b.259">De Vivo et al 2002b</xref>, <xref ref-type="bibr" rid="glut1.REF.pons.2010.275">Pons et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>].</p>
          <p><bold>Non-epileptic Glut1-DS</bold> includes a broad phenotypic spectrum that has expanded over the past few years as more affected individuals have been identified. Paroxysmal non-epileptic manifestations that have been reported include intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. Several disorders including dystonia 9, dystonia 18, atypical childhood absence epilepsy, and myoclonic astatic epilepsy are now known to be caused by Glut1 deficiency [<xref ref-type="bibr" rid="glut1.REF.chinnery.2010.649">Chinnery 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>].</p>
          <p><bold>Seizures.</bold> Seizures in classic early-onset Glut1-DS, which usually begin between age one and six months, are often the first clinical indication of brain dysfunction. In some infants, apneic episodes and abnormal episodic eye movements indistinguishable from opsoclonus may precede the onset of seizures. Infantile focal seizures are clinically fragmented (i.e., non-generalized; typical at this age) and may include paroxysmal eye movements, cyanotic spells, and complex absence and atonic seizures. The electroencephalogram (EEG) demonstrates multifocal spike discharges in infancy.</p>
          <p>With further brain maturation, the seizures become synchronized and manifest clinically as generalized events associated with 3- to 4-Hz spike and wave discharges. Several seizure types have been described: generalized tonic or clonic, focal, myoclonic, atypical absence, atonic, and unclassified [<xref ref-type="bibr" rid="glut1.REF.leary.2003.701">Leary et al 2003</xref>].</p>
          <p>The frequency of seizures varies among individuals: some experience daily events; others have only occasional seizures separated by days, weeks, or months. Seizure frequency does not correlate with phenotypic severity.</p>
          <p>Some individuals with Glut1-DS never have a clinical seizure [<xref ref-type="bibr" rid="glut1.REF.von_moers.2002.941">von Moers et al 2002</xref>, <xref ref-type="bibr" rid="glut1.REF.leary.2003.701">Leary et al 2003</xref>]. About 10%-15% of cases, diagnosed thus far, never have had clinical seizures [<xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>
<xref ref-type="bibr" rid="glut1.REF.pong.2012.1503">Pong et al 2012</xref>, <xref ref-type="bibr" rid="glut1.REF.pearson.2013.342">Pearson et al 2013</xref>].</p>
          <p><bold>Intellectual disability.</bold> Varying degrees of speech and language impairment are observed in all affected individuals.</p>
          <p>Dysarthria is common and is accompanied by dysfluency (i.e., excessively interrupted speech).</p>
          <p>Both receptive and expressive language skills are affected, with expressive language skills being disproportionately affected.</p>
          <p>Varying degrees of cognitive impairment, ranging from learning disabilities to severe intellectual disability, are observed. Minimally affected individuals have estimated IQ scores in the normal range.</p>
          <p>Social adaptive behavior is an exceptional strength. Individuals with Glut1-DS tend to be comfortable in group and school settings and interact well with others. Autistic spectrum disorders appear to be under-represented in those with Glut1-DS.</p>
          <p><bold>Movement disorders.</bold> A complex movement disorder is commonly seen and is characterized by ataxia, dystonia, and chorea which may be continuous, paroxysmal, or continuous with fluctuations determined by environmental stressors [<xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.pons.2010.275">Pons et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.pearson.2013.342">Pearson et al 2013</xref>, <xref ref-type="bibr" rid="glut1.REF.alter.2015.160">Alter et al 2015</xref>]. Often, paroxysmal worsening occurs before meals, during fasting, or with infectious stress.</p>
          <p><xref ref-type="bibr" rid="glut1.REF.pons.2010.275">Pons et al [2010]</xref> described the frequency of abnormal movements in 57 persons with Glut1-DS. Clinical findings included the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Gait disturbance (89%), the most frequent being ataxia and spasticity together or ataxia alone</p>
            </list-item>
            <list-item>
              <p>Action limb dystonia (86%)</p>
            </list-item>
            <list-item>
              <p>Mild chorea (75%)</p>
            </list-item>
            <list-item>
              <p>Cerebellar action tremor (70%)</p>
            </list-item>
            <list-item>
              <p>Non-epileptic paroxysmal events (28%)</p>
            </list-item>
            <list-item>
              <p>Dyspraxia (21%)</p>
            </list-item>
            <list-item>
              <p>Myoclonus (16%)</p>
            </list-item>
          </list>
          <p>The 40 individuals on a ketogenic diet had less severe gait disturbances, but more complex movement disorders than those on a conventional diet [<xref ref-type="bibr" rid="glut1.REF.pons.2010.275">Pons et al 2010</xref>], an observation suggesting that the extrapyramidal and cerebellar findings are more apparent in the milder phenotypes.</p>
          <p>Paroxysmal exercise-induced dyskinesia and epilepsy (previously known as dystonia 18 [<bold>DYT18</bold>] [<xref ref-type="bibr" rid="glut1.REF.suls.2008.1831">Suls et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.weber.2008.2157">Weber et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.zorzi.2008.146">Zorzi et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.urbizu.2010.110">Urbizu et al 2010</xref>]) and paroxysmal choreoathetosis with spasticity (previously known as dystonia 9 [<bold>DYT9</bold>] [<xref ref-type="bibr" rid="glut1.REF.weber.2011.959">Weber et al 2011</xref>]) are now recognized to be part of the phenotypic spectrum of Glut1-DS.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>DYT18</bold> differs clinically from classic Glut1-DS in that most affected individuals appear to have a normal interictal neurologic examination and a normal head circumference, and experience exercise-induced dyskinesias and later-onset seizures [<xref ref-type="bibr" rid="glut1.REF.suls.2008.1831">Suls et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.weber.2008.2157">Weber et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.zorzi.2008.146">Zorzi et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.urbizu.2010.110">Urbizu et al 2010</xref>]. The CSF glucose concentrations tend to be higher (41-52 mg/dL) than those in classic Glut1-DS [<xref ref-type="bibr" rid="glut1.REF.de_vivo.2008.877">De Vivo &#x00026; Wang 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>The two families with <bold>DYT9</bold> had paroxysmal, mainly exercise-induced dyskinesia with onset between ages one and 15 years [<xref ref-type="bibr" rid="glut1.REF.weber.2011.959">Weber et al 2011</xref>] caused by heterozygous <italic toggle="yes">SLC2A1</italic> pathogenic variants (<xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Arg212Cys</xref> and <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Arg126Cys</xref>). Dyskinesia triggers included prolonged exercise, anxiety, and emotional stress. The frequency of dyskinesias decreased or stopped later in life. Other associated findings included progressive spastic paraparesis with onset in early adulthood, mild gait ataxia, mild-to-moderate cognitive impairment, and epileptic seizures.</p>
            </list-item>
          </list>
          <p>Other paroxysmal events have been reported [<xref ref-type="bibr" rid="glut1.REF.overwegplandsoen.2003.559">Overweg-Plandsoen et al 2003</xref>, <xref ref-type="bibr" rid="glut1.REF.p_rezdue_as.2009.1410">P&#x000e9;rez-Due&#x000f1;as et al 2009</xref>, <xref ref-type="bibr" rid="glut1.REF.pons.2010.275">Pons et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.urbizu.2010.110">Urbizu et al 2010</xref>]. It is unclear whether these events represent epileptic or non-epileptic phenomena. These neurologic signs, which generally fluctuate and may be influenced by factors such as fasting or fatigue, include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Confusion</p>
            </list-item>
            <list-item>
              <p>Lethargy</p>
            </list-item>
            <list-item>
              <p>Somnolence</p>
            </list-item>
            <list-item>
              <p>Recurrent headaches, migraines</p>
            </list-item>
            <list-item>
              <p>Sleep disturbances</p>
            </list-item>
            <list-item>
              <p>Hemiparesis</p>
            </list-item>
            <list-item>
              <p>Total body paralysis</p>
            </list-item>
            <list-item>
              <p>Intermittent ataxia</p>
            </list-item>
            <list-item>
              <p>Chorea</p>
            </list-item>
            <list-item>
              <p>Action limb dystonia</p>
            </list-item>
            <list-item>
              <p>Cerebellar action tremor</p>
            </list-item>
            <list-item>
              <p>Writer&#x02019;s cramp</p>
            </list-item>
            <list-item>
              <p>Dystonic tremor (DT); described as the only finding in a mother and daughter [<xref ref-type="bibr" rid="glut1.REF.roubergue.2011.483">Roubergue et al 2011</xref>]</p>
            </list-item>
            <list-item>
              <p>Parkinsonism</p>
            </list-item>
            <list-item>
              <p>Myoclonus</p>
            </list-item>
            <list-item>
              <p>Dyspraxia</p>
            </list-item>
            <list-item>
              <p>Non-kinesigenic dyskinesias</p>
            </list-item>
          </list>
          <p><bold>Microcephaly.</bold> Thirty-two of 58 persons with Glut1-DS had microcephaly ranging from mild (&#x0003c;1 SD below the mean in 14 patients), moderate (&#x0003c;2 SD below the mean in 10) to severe (&#x0003c;3 SD below the mean in 8).</p>
        </sec>
        <sec id="glut1.Pathophysiology">
          <title>Pathophysiology</title>
          <p>The disease manifestations can be explained in terms of current understanding of glucose transport in the brain: glucose is the principal fuel source for brain metabolism; the glucose transporter, Glut1 (solute carrier family 2, facilitated glucose transporter 1), the protein product of <italic toggle="yes">SLC2A1</italic>, is the fundamental vehicle that facilitates glucose entry into the brain. The cerebral metabolic rate for glucose (which is low during fetal development) increases linearly after birth, peaks around age three years, remains high for the remainder of the first decade of life, and declines gradually during the second decade of life to the rate of glucose utilization seen in early adulthood. It thus appears that the risk for clinical manifestations during fetal development is low and then rises throughout infancy and early childhood.</p>
          <p>Human and animal data suggest that the margin of safety for glucose transport across the blood-brain barrier to meet the needs of brain metabolism and cerebral function is narrow. A milder clinical phenotype with intermittent symptoms (epilepsy, dyskinesias, and ataxia) may be predicted with 25%-35% reduction in Glut1 transporter function [<xref ref-type="bibr" rid="glut1.REF.rotstein.2010.955">Rotstein et al 2010</xref>]; a more severe phenotype results from greater reductions (perhaps 40%-75%) [<xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>].</p>
          <p>The erythrocyte glucose uptake assay is a functional surrogate measure of residual Glut1 transporter function. Individuals displaying the classic phenotype have on average a 50% uptake assay, resulting from pathogenic loss-of-function variants that result in 50% reduction in Glut1 activity. Absence of Glut1 transporter expression is embryonic lethal [<xref ref-type="bibr" rid="glut1.REF.wang.2006.1169">Wang et al 2006</xref>].</p>
        </sec>
        <sec id="glut1.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>A correlation between the specific type of <italic toggle="yes">SLC2A1</italic> pathogenic variant and the clinical severity has been noted [<xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]. A clinical scoring system, developed to classify phenotypic severity for mitochondrial diseases and Glut1-DS [<xref ref-type="bibr" rid="glut1.REF.kaufmann.2004.1297">Kaufmann et al 2004</xref>], has been used to correlate phenotype with other markers including genotype [<xref ref-type="bibr" rid="glut1.REF.levy.2010.129">Levy et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.rotstein.2010.955">Rotstein et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>].</p>
          <p>Fifty-three affected individuals were stratified clinically according to the Columbia Neurological Score (CNS) into four groups [<xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Minimal (CNS 70-76)</p>
            </list-item>
            <list-item>
              <p>Mild (CNS 60-69)</p>
            </list-item>
            <list-item>
              <p>Moderate (CNS 50-59)</p>
            </list-item>
            <list-item>
              <p>Severe (CNS 40-49)</p>
            </list-item>
          </list>
          <p>Comparison of the type of <italic toggle="yes">SLC2A1</italic> heterozygous pathogenic variants among the four groups revealed the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Missense variants occurred predominantly in the mild and moderate clinical categories.</p>
            </list-item>
            <list-item>
              <p>Splice site and nonsense variants and insertions, deletions, and exon deletions occurred almost exclusively in the moderate and severe clinical categories.</p>
            </list-item>
            <list-item>
              <p>Complete gene deletions clustered in the severe clinical category.</p>
            </list-item>
          </list>
          <p>A significant inverse correlation (R<sup>2</sup> = 0.94) was observed between the median values of the erythrocyte 3-O-methyl-D- glucose uptake and the clinical severity as determined by the Columbia Neurological Score. Thus, the erythrocyte glucose uptake is an indication of the functional effect of the pathogenic variant.</p>
          <p>Many pathogenic variants have been identified [<xref ref-type="bibr" rid="glut1.REF.wang.2005.111">Wang et al 2005</xref>, <xref ref-type="bibr" rid="glut1.REF.pascual.2008.16732">Pascual et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.wang.2008.538">Wang et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]; several mutation hot spots and gene regions have been detected:</p>
          <list list-type="bullet">
            <list-item>
              <p>Three individuals (each from a different family) have a mild clinical phenotype (as determined by the CNS) and a heterozygous <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Arg333Trp</xref> pathogenic missense variant.</p>
            </list-item>
            <list-item>
              <p>Twelve individuals have a heterozygous pathogenic missense variant at amino acid residue arginine 126.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Five had a mild phenotype: three members of one family with a <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Arg126His</xref> pathogenic variant [<xref ref-type="bibr" rid="glut1.REF.brockmann.2001.476">Brockmann et al 2001</xref>] and two members of one family with a <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Arg126Cys</xref> pathogenic variant [<xref ref-type="bibr" rid="glut1.REF.ho.2001a.s125">Ho et al 2001a</xref>].</p>
                </list-item>
                <list-item>
                  <p>Five with either the classic phenotype or the non-epileptic phenotype had a p.Arg126Cys pathogenic variant [<xref ref-type="bibr" rid="glut1.REF.zorzi.2008.146">Zorzi et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>].</p>
                </list-item>
                <list-item>
                  <p>Two monozygotic twin brothers with paroxysmal choreoathetosis and progressive spastic paraparesis (formerly known as DYT9) were heterozygous for the p.Arg126Cys pathogenic variant [<xref ref-type="bibr" rid="glut1.REF.weber.2011.959">Weber et al 2011</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A significant fraction (5/21) of pathogenic variants is located in a vulnerable region of the Glut 1 protein that involves the fourth transmembrane domain encoded by exon 4, suggesting a critical functional disturbance associated with structural alterations in this region of the protein [<xref ref-type="bibr" rid="glut1.REF.pascual.2008.16732">Pascual et al 2008</xref>].</p>
            </list-item>
            <list-item>
              <p>One individual had a <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Arg126Leu</xref> pathogenic variant in <italic toggle="yes">trans</italic> configuration with a <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Lys256Val</xref> pathogenic variant associated with a severe phenotype [<xref ref-type="bibr" rid="glut1.REF.pascual.2008.16732">Pascual et al 2008</xref>]. The father, who was clinically well, had neither missense variant. The asymptomatic mother was heterozygous for the p.Lys256Val pathogenic variant. Mutagenesis studies in <italic toggle="yes">Xenopus</italic> oocytes showed that in an uptake study under zero-trans influx conditions the p.Arg126Leu missense variant is more pathogenic than the p.Lys256Val missense variant. Therefore, the asymptomatic mother may have sufficient residual Glut1 activity to allow her to function normally. (Her glucose uptake assay revealed 83% residual activity; values of &#x0003e;74% residual activity correlate with a clinically normal state.) It is unclear whether synergy between the two pathogenic missense variants is causing a severe phenotype in the child who is a compound heterozygote [<xref ref-type="bibr" rid="glut1.REF.rotstein.2010.955">Rotstein et al 2010</xref>].</p>
            </list-item>
            <list-item>
              <p>Three individuals heterozygous for the <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Thr295Met</xref> pathogenic variant had:</p>
              <list list-type="bullet">
                <list-item>
                  <p>A similar early-onset classic phenotype including monthly seizures beginning in infancy, developmental delay, ataxia, microcephaly, and language deficit;</p>
                </list-item>
                <list-item>
                  <p>Hypoglycorrhachia and low normal CSF lactate concentrations;</p>
                </list-item>
                <list-item>
                  <p>Normal erythrocyte zero-trans influx of 3-OMG.</p>
                  <p>Mutagenesis studies suggest that p.Thr295Met specifically affects glucose flux by perturbing efflux rather than influx. These findings explain the seemingly paradoxic findings of Glut1-DS with hypoglycorrhachia and &#x0201c;normal&#x0201d; erythrocyte glucose uptake [<xref ref-type="bibr" rid="glut1.REF.wang.2008.538">Wang et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.fujii.2011.316">Fujii et al 2011</xref>]. Furthermore, this pathogenic missense variant may be a kinetic variant, functioning normally at 4 degrees Centigrade (the temperature of the in vitro glucose uptake assay) and abnormally at body temperature [<xref ref-type="bibr" rid="glut1.REF.cunningham.2013.495">Cunningham &#x00026; Naftalin 2013</xref>]</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>A fourth individual heterozygous for the <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">p.Thr295Met</xref> pathogenic variant with a similar mild classic phenotype was reported [<xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>].</p>
            </list-item>
          </list>
        </sec>
        <sec id="glut1.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance in Glut1-DS inherited in an autosomal dominant manner is complete.</p>
          <p>An asymptomatic parent harboring the pathogenic variant implies a mosaic state.</p>
          <p>Fewer pathogenic variants may be transmitted as an autosomal recessive trait; carriers are asymptomatic [<xref ref-type="bibr" rid="glut1.REF.rotstein.2010.955">Rotstein et al 2010</xref>].</p>
        </sec>
        <sec id="glut1.Nomenclature">
          <title>Nomenclature</title>
          <p>Paroxysmal exercise-induced dyskinesia and epilepsy (also known as dystonia 18 [DYT18]) [<xref ref-type="bibr" rid="glut1.REF.suls.2008.1831">Suls et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.weber.2008.2157">Weber et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.zorzi.2008.146">Zorzi et al 2008</xref>, <xref ref-type="bibr" rid="glut1.REF.urbizu.2010.110">Urbizu et al 2010</xref>] and paroxysmal choreoathetosis with spasticity (DYT9) [<xref ref-type="bibr" rid="glut1.REF.weber.2011.959">Weber et al 2011</xref>] are now recognized to be part of the Glut1-DS phenotypic spectrum.</p>
        </sec>
        <sec id="glut1.Prevalence">
          <title>Prevalence</title>
          <p>No firm estimates of incidence and prevalence can be made, as cases have been reported worldwide and are biased by physician awareness of the disorder. Authors estimate the incidence/prevalence in Queensland, Australia at approximately 1:90,000, which is likely a conservative estimate under the conditions of ascertainment [<xref ref-type="bibr" rid="glut1.REF.coman.2006.263">Coman et al 2006</xref>].</p>
        </sec>
      </sec>
      <sec id="glut1.Genetically_Related_Allelic_Disord">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>Cryohydrocytosis, a form of dominantly inherited stomatocytosis that leads to hemolytic anemia induced by cold exposure, can be caused by pathogenic variants in <italic toggle="yes">SLC2A1</italic>. Findings include hemolytic anemia, hepatosplenomegaly, cataracts, seizures, intellectual disability, and movement disorder [<xref ref-type="bibr" rid="glut1.REF.flatt.2011.5267">Flatt et al 2011</xref>].</p>
      </sec>
      <sec id="glut1.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>The differential diagnosis of glucose transporter type 1 deficiency syndrome (Glut1-DS) includes the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Other causes of neuroglycopenia, such as conditions causing chronic or intermittent hypoglycemia (e.g., <related-object link-type="booklink" source-id="gene" document-id="hi" document-type="chapter">familial hyperinsulinism</related-object>)</p>
          </list-item>
          <list-item>
            <p>All causes of neonatal seizures and of acquired microcephaly; in particular, early presentations of <related-object link-type="booklink" source-id="gene" document-id="rett" document-type="chapter">Rett syndrome</related-object>, <related-object link-type="booklink" source-id="gene" document-id="angelman" document-type="chapter">Angelman syndrome</related-object>, and infantile forms of <related-object link-type="booklink" source-id="gene" document-id="ncl" document-type="chapter">neuronal ceroid-lipofuscinosis</related-object></p>
          </list-item>
          <list-item>
            <p>Opsoclonus-myoclonus syndrome</p>
          </list-item>
          <list-item>
            <p>Cryptogenic epileptic encephalopathies with developmental delays</p>
          </list-item>
          <list-item>
            <p>Familial epilepsies with autosomal dominant transmission</p>
          </list-item>
          <list-item>
            <p>Episodes of paroxysmal neurologic dysfunction responsive to or preventable by carbohydrate intake, especially when manifesting as alternating hemiparesis, ataxia, cognitive dysfunction, or seizures</p>
          </list-item>
          <list-item>
            <p>Movement disorders including dystonia (see <related-object link-type="booklink" source-id="gene" document-id="dystonia-ov" document-type="chapter">Dystonia Overview</related-object>)</p>
          </list-item>
        </list>
      </sec>
      <sec id="glut1.Management">
        <title>Management</title>
        <sec id="glut1.Evaluations_Following_Initial_Diag">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs of an individual diagnosed with glucose transporter type 1 deficiency syndrome (Glut1-DS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>EEG (pre-prandial and post-prandial tracings)</p>
            </list-item>
            <list-item>
              <p>Brain imaging, including FDG-PET in selected individuals</p>
            </list-item>
            <list-item>
              <p>Neuropsychological assessment</p>
            </list-item>
            <list-item>
              <p>Clinical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="glut1.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p><bold>Ketogenic diet.</bold> Diffusion of ketone bodies across the blood-brain barrier is facilitated by the monocarboxylic transporter 1(MCT1). The ketogenic diet, introduced as a treatment for Glut1-DS in 1991, primarily provides an alternative fuel for brain metabolism. The ketogenic diet creates chronic ketosis by largely replacing carbohydrates and proteins with lipids in varying ratios.</p>
          <p>Experience over the past two decades indicates that the ketogenic diet is well tolerated in most cases and is highly effective in controlling the seizures and improving gait disturbance. Of note, seizures may recur even with good dietary compliance [<xref ref-type="bibr" rid="glut1.REF.klepper.2005.302">Klepper et al 2005</xref>]. Even when seizures are controlled, affected individuals may continue to have neurobehavioral deficits involving cognition and social adaptive behavior [<xref ref-type="bibr" rid="glut1.REF.klepper.2002.449">Klepper et al 2002</xref>].</p>
          <p>In the authors&#x02019; experience, the neurologic outcome is influenced by the age at which treatment is initiated: affected individuals treated at a younger age have a better outcome [<xref ref-type="bibr" rid="glut1.REF.alter.2015.160">Alter et al 2015</xref>].</p>
          <p>Note: Because the ketogenic diet is deficient in L-carnitine, a co-factor that is essential for the metabolism of fats, dietary supplementation with 50 mg/kg/day of L-carnitine is recommended [<xref ref-type="bibr" rid="glut1.REF.de_vivo.1998.1216">De Vivo et al 1998</xref>].</p>
          <p>Affected individuals develop a mild compensated metabolic acidosis when ketotic.</p>
          <p><bold>Antiepileptic drugs (AEDs)</bold> are generally ineffective or afford only limited improvement in the absence of a ketogenic diet. Certain AEDs may be relatively contraindicated as adjunctive treatment in children on the ketogenic diet (see <xref ref-type="sec" rid="glut1.AgentsCircumstances_to_Avoid">Agents/Circumstances to Avoid</xref>).</p>
          <list list-type="bullet">
            <list-item>
              <p>Phenobarbital and valproic acid can inhibit Glut1 transport.</p>
            </list-item>
            <list-item>
              <p>Valproic acid may partially inhibit beta-oxidation of fatty acids.</p>
            </list-item>
            <list-item>
              <p>Acetazolamide, topiramate, and zonisamide inhibit carbonic anhydrase and may potentiate the metabolic acidosis. These agents also can cause kidney stones.</p>
            </list-item>
          </list>
          <p><bold>Alpha-lipoic acid</bold> (thioctic acid) also has been shown to facilitate glucose transport in Glut4-dependent cultured skeletal muscle cells. Preliminary in vitro studies with Glut1 transport systems have shown similar results. Thus, alpha-lipoic acid supplements have been recommended, without supportive clinical evidence, as a treatment for Glut1-DS. Response has been modest at best; however, the dose taken by mouth may be insufficient to approximate experimental conditions [<xref ref-type="bibr" rid="glut1.REF.kulikovaschupak.2001.s106">Kulikova-Schupak et al 2001</xref>].</p>
        </sec>
        <sec id="glut1.Prevention_of_Primary_Manifestatio">
          <title>Prevention of Primary Manifestations</title>
          <p>Clinical observations suggest that early diagnosis and treatment with a ketogenic diet is associated with improved neurologic outcome by nourishing the immature brain during this critical period of growth and development [<xref ref-type="bibr" rid="glut1.REF.alter.2015.160">Alter et al 2015</xref>].</p>
        </sec>
        <sec id="glut1.Prevention_of_Secondary_Complicati">
          <title>Prevention of Secondary Complications</title>
          <p>For those who are treated with the ketogenic diet:</p>
          <list list-type="bullet">
            <list-item>
              <p>L-carnitine supplementation to avoid carnitine deficiency</p>
            </list-item>
            <list-item>
              <p>Proper hydration and avoidance of carbonic anhydrase inhibitors to minimize likelihood of kidney stones.</p>
            </list-item>
            <list-item>
              <p>Avoid carbohydrate-containing foods, intravenous fluids, and medications that will interrupt the state of ketosis. Family care providers often need to serve as the &#x0201c;watch dogs&#x0201d; to intercept these indiscretions.</p>
            </list-item>
            <list-item>
              <p>Valproic acid treatment may be dangerous in individuals on a ketogenic diet because it increases the risk of a Reye-like illness. Additionally, valproic acid may inhibit glucose transport.</p>
            </list-item>
          </list>
        </sec>
        <sec id="glut1.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Blood ketone concentrations should be monitored daily, weekly or as needed to document the state of ketosis. A blood beta-hydroxybutyrate concentration of 3-5 mmol/L is recommended to insure a proper ketotic state.</p>
            </list-item>
            <list-item>
              <p>Urinary measurement of ketonuria is only qualitative, and may be falsely reassuring as a strongly positive urine test for ketones may correlate with hypoketonemia. Blood measurement of ketone concentration is the preferred method.</p>
            </list-item>
          </list>
        </sec>
        <sec id="glut1.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The following should be avoided:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Barbiturates.</bold> Generally, children with infantile-onset seizures are treated with phenobarbital, the most commonly used antiepileptic drug in this age group. In vitro studies indicate that barbiturates aggravate the Glut1 transport defect in erythrocytes of individuals with Glut1-DS [<xref ref-type="bibr" rid="glut1.REF.klepper.1999a.677">Klepper et al 1999a</xref>]. On occasion, parents have reported that phenobarbital did not improve their child&#x02019;s seizure control or may have worsened their child's clinical condition.</p>
            </list-item>
            <list-item>
              <p><bold>Methylxanthines (e.g., caffeine),</bold> which are known to inhibit transport of glucose by Glut1 [<xref ref-type="bibr" rid="glut1.REF.ho.2001b.254">Ho et al 2001b</xref>], also have been reported to worsen the clinical state of individuals with Glut1-DS [<xref ref-type="bibr" rid="glut1.REF.brockmann.2001.476">Brockmann et al 2001</xref>]. Thus, it is advisable for affected individuals to avoid coffee and other caffeinated beverages.</p>
            </list-item>
            <list-item>
              <p><bold>Valproic acid.</bold> The following studies suggest that valproic acid effects in vitro are mixed and the clinical consequences of valproic acid usage in patients with Glut1-DS cannot be predicted.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Valproic acid inhibited Glut1 transport activity in normal and Glut1-deficient erythrocytes by 20%-30%. In primary astrocytes as well as in normal and Glut1-deficient fibroblasts, sodium valproate inhibited glucose transport by 20%-40%, accompanied by an up to 60% down-regulation of GLUT1 mRNA expression [<xref ref-type="bibr" rid="glut1.REF.wong.2005.775">Wong et al 2005</xref>].</p>
                </list-item>
                <list-item>
                  <p>A study using cultured astrocytes from the Glut1-DS mouse model showed an upregulation of Glut1 activity at lower valproic acid concentrations presumably from the valproic acid associated inhibition of histone deacetylase activity [<xref ref-type="bibr" rid="glut1.REF.kim.2013.70">Kim et al 2013</xref>].</p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
        <sec id="glut1.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate at-risk newborns, infants, and other relatives at risk in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures. Molecular genetic testing can be used to clarify the genetic status of at-risk relatives if the pathogenic variant in the family is known.</p>
          <p>See <xref ref-type="sec" rid="glut1.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="glut1.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><bold>Triheptanoin</bold> is a specially designed synthetic triglyceride compound of three, seven-carbon (C7) fatty acids intended to provide affected individuals with the medium-length, odd-chain, fatty-acid heptanoate. Triheptanoin is metabolized rapidly in the liver to form a series of energy-containing metabolites, including heptanoate, which is further metabolized to 4-carbon (C4) and 5-carbon (C5) ketone bodies. Ketone bodies cross the blood-brain barrier via the monocarboxylate transporter, bypassing the deficient Glut1 transporter and providing alternative energy sources to the brain. The metabolites also have the ability to resupply intermediates of the tricarboxylic acid (TCA) cycle (i.e., anaplerosis) . A pilot study of the effects of ingestion of triheptanoin as a dietary supplement in individuals with Glut1 de&#x0fb01;ciency was conducted and the preliminary results of this trial showed increased oxygen cerebral metabolic rate (CMRO2), decreased seizures, and improved neuropsychological performance [<xref ref-type="bibr" rid="glut1.REF.pascual.2014.1255">Pascual et al 2014</xref>]. A Phase II randomized, double-blind, placebo-controlled, parallel-group study of the triheptanoin effects in those with Glut1-DS is currently enrolling affected persons who are currently not fully compliant with the ketogenic diet and continue to have seizures. The primary efficacy objective is reduction in seizure frequency.</p>
          <p><bold>Gene therapy.</bold> Murine <italic toggle="yes">Glut1</italic> was packaged into adeno-associated virus 9 (AAV9) and systemically introduced into a neonatal mouse model of Glut1 deficiency. Injected mutant mice and relevant controls were assessed during adult life. In AAV9-Glut1 treated mutants, Glut1 RNA and protein levels rose, CSF glucose levels were restored, brain size was normalized and motor defects corrected [<xref ref-type="bibr" rid="glut1.REF.monani.2014.s176">Monani et al 2014</xref>].</p>
          <p>These results provide important proof-of-concept data of the therapeutic effects of restoring Glut1protein function in Glut1-DS and represent an important step toward finding a disease-modifying treatment for the human disease.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="glut1.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="glut1.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Glucose transporter type 1 deficiency syndrome (Glut1-DS) is most commonly inherited in an autosomal dominant manner [<xref ref-type="bibr" rid="glut1.REF.brockmann.1999.a90">Brockmann et al 1999</xref>, <xref ref-type="bibr" rid="glut1.REF.brockmann.2001.476">Brockmann et al 2001</xref>, <xref ref-type="bibr" rid="glut1.REF.ho.2001a.s125">Ho et al 2001a</xref>, <xref ref-type="bibr" rid="glut1.REF.klepper.2001.63">Klepper et al 2001</xref>, <xref ref-type="bibr" rid="glut1.REF.wang.2001a.s125">Wang et al 2001a</xref>, <xref ref-type="bibr" rid="glut1.REF.wang.2005.111">Wang et al 2005</xref>] and affected individuals are heterozygous for the pathogenic variant.</p>
          <p>Two families have demonstrated autosomal recessive inheritance [<xref ref-type="bibr" rid="glut1.REF.klepper.2009.207">Klepper et al 2009</xref>, <xref ref-type="bibr" rid="glut1.REF.rotstein.2010.955">Rotstein et al 2010</xref>]; one of the families was consanguineous.</p>
        </sec>
        <sec id="glut1.Risk_to_Family_Members__Autosomal">
          <title>Risk to Family Members &#x02013; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>About 10% of individuals diagnosed with Glut1-DS have an affected parent [<xref ref-type="bibr" rid="glut1.REF.wang.2005.111">Wang et al 2005</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]. About 90% of individuals with Glut-DS have a <italic toggle="yes">de novo</italic> pathogenic variant of <italic toggle="yes">SCL2A1</italic>.</p>
            </list-item>
            <list-item>
              <p>The degree of impairment in an affected parent may be mild or non-existent. Somatic mosaicism for the <italic toggle="yes">SLC2A1</italic> pathogenic variant may explain this observation [<xref ref-type="bibr" rid="glut1.REF.wang.2001b.s124">Wang et al 2001b</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of an individual with Glut1-DS and no known family history of Glut1 DS include comparison of erythrocyte glucose uptake with control values and molecular genetic testing of both parents when the <italic toggle="yes">SLC2A1</italic> pathogenic variant in the proband has been identified.</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent is affected or has an <italic toggle="yes">SLC2A1</italic> pathogenic variant, the risk is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low, but not zero since the clinically unaffected parent may have germline mosaicism for the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">SLC2A1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
            <list-item>
              <p>Although no instances of germline mosaicism have been reported, it remains a possibility, especially since somatic mosaicism has been reported [<xref ref-type="bibr" rid="glut1.REF.wang.2001b.s124">Wang et al 2001b</xref>].</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with Glut1-DS has a 50% chance of inheriting the <italic toggle="yes">SLC2A1</italic> pathogenic variant and being clinically affected.</p>
          <p><bold>Other family members of a proband.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, other family members are also at risk.</p>
        </sec>
        <sec id="glut1.Risk_to_Family_Members__Autosomal_1">
          <title>Risk to Family Members &#x02013; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of an individual with an autosomal recessive Glut1-DS are obligate heterozygotes (i.e., carriers of one <italic toggle="yes">SLC2A1</italic> pathogenic variant).</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes (carriers) are asymptomatic and are not at risk of developing the disorder.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with an autosomal recessive form of Glut1-DS are obligate heterozygotes (carriers) for a pathogenic variant in <italic toggle="yes">SLC2A1</italic>.</p>
        </sec>
        <sec id="glut1.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="glut1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the variant occurred <italic toggle="yes">de novo</italic> in the proband. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="glut1.Prenatal_Testing_and_Preimplantati">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">SLC2A1</italic> pathogenic variant(s) have been identified in an affected family member, prenatal diagnosis for a pregnancy at increased risk and preimplantation genetic diagnosis for Glut1-DS are possible.</p>
        </sec>
      </sec>
      <sec id="glut1.Resources">
        <title>Resources</title>
      </sec>
      <sec id="glut1.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> The genomic sequence is approximately 35 kb, with ten exons and nine introns. The promoter region contains sequence elements for transcription factors, including a TATA box and a phorbol ester-responsive element. Two enhancer elements within <italic toggle="yes">SLC2A1</italic> have been identified: the first is located between 3.3 and 2.7 kb upstream from the transcription initiation site; the second is located within the second intron, between 16.7 kb and 18.0 kb downstream from the transcription initiation site. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="glut1" object-id="glut1.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Benign variants.</bold> No benign variants have been identified.</p>
        <p><bold>Pathogenic variants.</bold> See <xref ref-type="table" rid="glut1.T.selected_slc2a1_pathogenic_varia">Table 2</xref> for summary.</p>
        <p>Exon, multiexon, and whole-gene deletions have been reported [<xref ref-type="bibr" rid="glut1.REF.seidner.1998.188">Seidner et al 1998</xref>, <xref ref-type="bibr" rid="glut1.REF.wang.2000.224">Wang et al 2000</xref>, <xref ref-type="bibr" rid="glut1.REF.vermeer.2007.380">Vermeer et al 2007</xref>, <xref ref-type="bibr" rid="glut1.REF.leen.2010.655">Leen et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.levy.2010.129">Levy et al 2010</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>].</p>
        <table-wrap id="glut1.T.selected_slc2a1_pathogenic_varia" orientation="portrait" position="anchor">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">SLC2A1</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.376C&#x0003e;T</td>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg126Cys</td>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_006516.2">NM_006516.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_006507.2">NP_006507.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.377G&#x0003e;A</td>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg126His</td>
              </tr>
              <tr>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.377G&#x0003e;T</td>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg126Leu</td>
              </tr>
              <tr>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.766_767delAAinsGT</td>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Lys256Val</td>
              </tr>
              <tr>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.997C&#x0003e;T</td>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg333Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.884C&#x0003e;T</td>
                <td headers="hd_h_glut1.T.selected_slc2a1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr295Met</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> Glut1 (solute carrier family 2, facilitated glucose transporter member 1) is a 492-amino acid, 45- or 55-kd (depending on the state of glycosylation) integral membrane protein with intracellular amino and carboxyl termini and 12 transmembrane domains, which probably span the plasma membrane as alpha-helices and line a pore through which glucose and other substrates are translocated. Glut1 is expressed at the blood-brain barrier facilitating transport of glucose across the luminal and abluminal endothelial membranes of the cerebral microvessel and facilitating transport of glucose across the astroglial plasma membrane, thus representing the fundamental vehicle by which glucose enters the brain. Additionally, the transporter recognizes other substrates such as galactose, glycopeptides, water, and dihydroascorbic acid (DHA), some or all of which may also be translocated in significant amounts, although the pathophysiologic role of these processes in Glut1-DS is not known [<xref ref-type="bibr" rid="glut1.REF.klepper.1998.286">Klepper et al 1998</xref>].</p>
        <p><bold>Abnormal gene product.</bold> Abnormal Glut1 protein results from frameshift variants that predict a truncated protein, pathogenic missense variants, or, in the most severe cases, absent protein production from a deleted allele [<xref ref-type="bibr" rid="glut1.REF.seidner.1998.188">Seidner et al 1998</xref>, <xref ref-type="bibr" rid="glut1.REF.wang.2000.224">Wang et al 2000</xref>, <xref ref-type="bibr" rid="glut1.REF.levy.2010.129">Levy et al 2010</xref>]. Loss of function with missense variants and deletions ranges from minimal kinetic abnormalities to loss of protein synthesis from the mutated allele.</p>
        <p>Almost all individuals with the diagnosis of Glut1-DS have shown decreased erythrocyte 3-OMG uptake (zero-trans influx) values that are approximately 50% of control values [<xref ref-type="bibr" rid="glut1.REF.wang.2005.111">Wang et al 2005</xref>, <xref ref-type="bibr" rid="glut1.REF.fujii.2007.92">Fujii et al 2007</xref>, <xref ref-type="bibr" rid="glut1.REF.fujii.2011.316">Fujii et al 2011</xref>, <xref ref-type="bibr" rid="glut1.REF.yang.2011.996">Yang et al 2011</xref>]. Values in affected individuals have ranged from 36% to 74%. In all cases, the normal allele contributes approximately 50% of functional Glut1 protein to the plasma membrane [<xref ref-type="bibr" rid="glut1.REF.wang.2005.111">Wang et al 2005</xref>].</p>
        <p>Two families with Glut1-DS inherited in an autosomal recessive manner have been described [<xref ref-type="bibr" rid="glut1.REF.rotstein.2010.955">Rotstein et al 2010</xref>]:</p>
        <list list-type="bullet">
          <list-item>
            <p>In one family, a severely affected boy inherited a mutated allele from his asymptomatic heterozygous mother. A <italic toggle="yes">de novo</italic> pathogenic variant occurred in the paternal allele, producing compound heterozygosity.</p>
          </list-item>
          <list-item>
            <p>In another family, two mildly affected sisters were homozygous for the Arg468Trp pathogenic missense variant, which they inherited from their asymptomatic heterozygous consanguineous parents. 3-OMG RBC uptake studies in the older and younger sisters were 66% and 63%, and in the mother and father were 84% and 83%, compared with an intra-assay control. The pattern of inheritance is determined by the relative pathogenicity of the variant and the associated residual Glut1 activity.</p>
          </list-item>
        </list>
      </sec>
      <sec id="glut1.References">
        <title>References</title>
        <sec id="glut1.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="glut1.Literature_Cited.reflist0">
            <ref id="glut1.REF.alter.2015.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alter</surname>
                    <given-names>AS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinton</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <article-title>Long-Term Clinical Course of Glut1 Deficiency Syndrome.</article-title>
                <source>J Child Neurol.</source>
                <year>2015</year>
                <volume>30</volume>
                <fpage>160</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24789115</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.brockmann.1999.a90">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenke</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moers</surname>
                    <given-names>AV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weise</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Epilepsy with seizures after fasting and retardation: the first familial cases of glucose transporter protein (GLUT1) deficiency.</article-title>
                <source>Eur J Pediatr Neurol</source>
                <volume>3</volume>
                <fpage>A90</fpage>
                <lpage>1</lpage>
              </element-citation>
            </ref>
            <ref id="glut1.REF.brockmann.2001.476">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenke</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Moers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kranz-Eble</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbarg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Autosomal dominant glut-1 deficiency syndrome and familial epilepsy.</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>476</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">11603379</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.chinnery.2010.649">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                </person-group>
                <article-title>Defining neurogenetic phenotypes (or how to compare needles in haystacks).</article-title>
                <source>Brain.</source>
                <year>2010</year>
                <volume>133</volume>
                <fpage>649</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">20157007</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.coman.2006.263">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coman</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sinclair</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burke</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Appleton</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelekanos</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Neil</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>GB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bowling</surname>
                    <given-names>FG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGill</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Seizures, ataxia, developmental delay and the general paediatrician: glucose transporter 1 deficiency syndrome.</article-title>
                <source>J Paediatr Child Health.</source>
                <year>2006</year>
                <volume>42</volume>
                <fpage>263</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16712556</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.cunningham.2013.495">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Naftalin</surname>
                    <given-names>RJ</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Implications of aberrant temperature sensitive glucose transport via the glucose transporter deficiency mutant (GLUT1DS) T295M for the alternate-access and fixed-site transport models.</article-title>
                <source>J Membr Biol.</source>
                <volume>246</volume>
                <fpage>495</fpage>
                <lpage>511</lpage>
                <pub-id pub-id-type="pmid">23740044</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.de_vivo.1998.1216">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohan</surname>
                    <given-names>TP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coulter</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dreifuss</surname>
                    <given-names>FE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenwood</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordli</surname>
                    <given-names>DR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>WD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stafstrom</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tein</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <article-title>L-carnitine supplementation in childhood epilepsy: current perspectives.</article-title>
                <source>Epilepsia.</source>
                <year>1998</year>
                <volume>39</volume>
                <fpage>1216</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">9821988</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.de_vivo.a">
              <mixed-citation publication-type="other">De Vivo DC, Leary L, Wang D (2002a) Glucose transporter 1 deficiency syndrome and other glycolytic defects. J Child Neurol. 17 Suppl 3:3S15-23</mixed-citation>
            </ref>
            <ref id="glut1.REF.de_vivo.1991.703">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trifiletti</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacobson</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronen</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Behmand</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harik</surname>
                    <given-names>SI</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay.</article-title>
                <source>N Engl J Med.</source>
                <volume>325</volume>
                <fpage>703</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">1714544</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.de_vivo.2008.877">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Glut1 Deficiency: CSF Glucose. How low is too low?</article-title>
                <source>Revue Neurologique</source>
                <volume>164</volume>
                <fpage>877</fpage>
                <lpage>80</lpage>
                <pub-id pub-id-type="pmid">18990414</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.de_vivo.2002b.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                </person-group>
                <year>2002b</year>
                <article-title>Glucose transporter protein syndromes.</article-title>
                <source>Int Rev Neurobiol</source>
                <volume>51</volume>
                <fpage>259</fpage>
                <lpage>88</lpage>
                <pub-id pub-id-type="pmid">12420362</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.flatt.2011.5267">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flatt</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guizouarn</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burton</surname>
                    <given-names>NM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Borgese</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsyth</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldwin</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levinson</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quittet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aguilar-Martinez</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delaunay</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>GW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bruce</surname>
                    <given-names>LJ</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Stomatin-deficient cryohydrocytosis results from mutations in SLC2A1: a novel form of GLUT1 deficiency syndrome.</article-title>
                <source>Blood.</source>
                <volume>118</volume>
                <fpage>5267</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">21791420</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.fujii.2007.92">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyajima</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsang</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shirasaka</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kudo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Three Japanese patients with glucose transporter type 1 deficiency syndrome.</article-title>
                <source>Brain Dev.</source>
                <volume>29</volume>
                <fpage>92</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">16949238</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.fujii.2011.316">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morimoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoshioka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Law</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>T295M-associated Glut1 deficiency syndrome with normal erythrocyte 3-OMG uptake.</article-title>
                <source>Brain Dev.</source>
                <volume>33</volume>
                <fpage>316</fpage>
                <lpage>20</lpage>
                <pub-id pub-id-type="pmid">20630673</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.ho.2001a.s125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinton</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vasilescu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanson</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wolf</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Glut-1 deficiency syndrome: Autosomal dominant transmission of the R126C missense mutation</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>S125</fpage>
              </element-citation>
            </ref>
            <ref id="glut1.REF.ho.2001b.254">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbarg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>Glucose transporter type 1 deficiency syndrome (Glut1DS): methylxanthines potentiate GLUT1 haploinsufficiency in vitro.</article-title>
                <source>Pediatr Res</source>
                <volume>50</volume>
                <fpage>254</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">11477212</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.kaufmann.2004.1297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kaufmann</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shungu</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sano</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shanske</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Cerebral lactic acidosis correlates with neurological impairment in MELAS.</article-title>
                <source>Neurology.</source>
                <volume>62</volume>
                <fpage>1297</fpage>
                <lpage>302</lpage>
                <pub-id pub-id-type="pmid">15111665</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.kim.2013.70">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Valproic acid enhances glucose transport in the cultured brain astrocytes of glucose transporter 1 heterozygous mice.</article-title>
                <source>J Child Neurol.</source>
                <volume>28</volume>
                <fpage>70</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">22532550</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.klepper.1999a.677">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbarg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vera</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1999a</year>
                <article-title>GLUT1-deficiency: barbiturates potentiate haploinsufficiency in vitro.</article-title>
                <source>Pediatr Res</source>
                <volume>46</volume>
                <fpage>677</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">10590023</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.klepper.1999b.116">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Alvarez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Driscoll</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parides</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1999b</year>
                <article-title>Erythrocyte 3-O-methyl-D-glucose uptake assay for diagnosis of glucose-transporter-protein syndrome.</article-title>
                <source>J Clin Lab Anal</source>
                <volume>13</volume>
                <fpage>116</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">10323476</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.klepper.2002.449">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leiendecker</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bredahl</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Athanassopoulos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heinen</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gertsen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florcken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Metz</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Introduction of a ketogenic diet in young infants.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>25</volume>
                <fpage>449</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">12555938</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.klepper.2009.207">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsaid</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamsteeg</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leferink</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben-Omran</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Autosomal recessive inheritance of GLUT1 deficiency syndrome.</article-title>
                <source>Neuropediatrics</source>
                <volume>40</volume>
                <fpage>207</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">20221955</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.klepper.2005.302">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leiendecker</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gertsen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Binder</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leferink</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hertzberg</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>N&#x000e4;ke</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Seizure control and acceptance of the ketogenic diet in GLUT1 deficiency syndrome: a 2- to 5-year follow-up of 15 children enrolled prospectively.</article-title>
                <source>Neuropediatrics.</source>
                <volume>36</volume>
                <fpage>302</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16217704</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.klepper.1998.286">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vera</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Deficient transport of dehydroascorbic acid in the glucose transporter protein syndrome.</article-title>
                <source>Ann Neurol</source>
                <volume>44</volume>
                <fpage>286</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">9708557</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.klepper.2001.63">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verrips</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guertsen</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Herrmann</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kutzick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florcken</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Autosomal dominant transmission of GLUT1 deficiency.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>63</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11136715</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.kulikovaschupak.2001.s106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kulikova-Schupak</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kranz-Eble</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <article-title>Stimulation of GLUT-1 gene transcription by thioctic acid and its potential therapeutic value in Glut-1 deficiency syndrome (GLUT1-DS).</article-title>
                <source>J Inherit Metab Dis</source>
                <year>2001</year>
                <volume>24</volume>
                <fpage>S106</fpage>
              </element-citation>
            </ref>
            <ref id="glut1.REF.leary.2003.701">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leary</surname>
                    <given-names>LD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nordli</surname>
                    <given-names>DR</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome.</article-title>
                <source>Epilepsia</source>
                <volume>44</volume>
                <fpage>701</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12752470</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.leen.2010.655">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leen</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leferink</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hofste</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Engelen</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arthur</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bahi-Buisson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ballhausen</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bekhof</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bogaert</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carrilho</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabrol</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Champion</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coldwell</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clayton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Donner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Evangeliou</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebinger</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrell</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Forsyth</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Goede</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gross</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grunewald</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holthausen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jayawant</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachlan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laugel</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leppig</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marina</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martorell</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McMenamin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meuwissen</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundy</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nilsson</surname>
                    <given-names>NO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Panzer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poll-The</surname>
                    <given-names>BT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauscher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouselle</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandvig</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffner</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheridan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simpson</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sykora</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomlinson</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trounce</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Webb</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weschke</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.</article-title>
                <source>Brain.</source>
                <volume>133</volume>
                <fpage>655</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">20129935</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.leen.2013.1440">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leen</surname>
                    <given-names>WG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wevers</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamsteeg</surname>
                    <given-names>EJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Cerebrospinal fluid analysis in the workup of GLUT1 deficiency syndrome: a systematic review.</article-title>
                <source>JAMA Neurol.</source>
                <volume>70</volume>
                <fpage>1440</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">23999624</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.levy.2010.129">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ullner</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nahum</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Uncovering microdeletions in patients with severe Glut-1 deficiency syndrome using SNP oligonucleotide microarray analysis.</article-title>
                <source>Mol Genet Metab</source>
                <volume>100</volume>
                <fpage>129</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">20382060</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.monani.2014.s176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Monani</surname>
                    <given-names>UR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shetler</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Gene Therapy for Glut1 Deficiency Syndrome.</article-title>
                <source>Ann Neurol.</source>
                <volume>76</volume>
                <supplement>Suppl 18</supplement>
                <fpage>S176</fpage>
              </element-citation>
            </ref>
            <ref id="glut1.REF.overwegplandsoen.2003.559">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Overweg-Plandsoen</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Groener</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onkenhout</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brouwer</surname>
                    <given-names>OF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bakker</surname>
                    <given-names>HD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>GLUT-1 deficiency without epilepsy--an exceptional case.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>26</volume>
                <fpage>559</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">14605501</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.pascual.2002.458">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Heertum</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Imaging the metabolic footprint of Glut1 deficiency on the brain.</article-title>
                <source>Ann Neurol</source>
                <volume>52</volume>
                <fpage>458</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">12325075</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.pascual.2008.16732">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants.</article-title>
                <source>J Biol Chem</source>
                <volume>283</volume>
                <fpage>16732</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">18387950</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.pascual.2014.1255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kelly</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hernandez</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheng</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Good</surname>
                    <given-names>LB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marin-Valencia</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>JY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hynan</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stavinoha</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roe</surname>
                    <given-names>CR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement.</article-title>
                <source>JAMA Neurol.</source>
                <volume>71</volume>
                <fpage>1255</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">25110966</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.p_rezdue_as.2009.1410">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Due&#x000f1;as</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prior</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fern&#x000e1;ndez-Alvarez</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Setoain</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Artuch</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Childhood chorea with cerebral hypotrophy: a treatable GLUT1 energy failure syndrome.</article-title>
                <source>Arch Neurol.</source>
                <volume>66</volume>
                <fpage>1410</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">19901175</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.pearson.2013.342">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akman</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinton</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).</article-title>
                <source>Curr Neurol Neurosci Rep.</source>
                <volume>13</volume>
                <fpage>342</fpage>
                <pub-id pub-id-type="pmid">23443458</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.pons.2010.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pons</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotstein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>The spectrum of movement disorders in Glut-1 deficiency.</article-title>
                <source>Mov Disord</source>
                <volume>25</volume>
                <fpage>275</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">20063428</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.pong.2012.1503">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pong</surname>
                    <given-names>AW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geary</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Natarajan</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes.</article-title>
                <source>Epilepsia</source>
                <volume>53</volume>
                <fpage>1503</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">22812641</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.rotstein.2010.955">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rotstein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Glut1 deficiency: inheritance pattern determined by haploinsufficiency.</article-title>
                <source>Ann Neurol</source>
                <volume>68</volume>
                <fpage>955</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20687207</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.roubergue.2011.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roubergue</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apartis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mesnage</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doummar</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Trocello</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roze</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taieb</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Villemeur</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vuillaumier-Barrot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidailhet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Dystonic tremor caused by mutation of the glucose transporter gene GLUT1.</article-title>
                <source>J Inherit Metab Dis</source>
                <volume>34</volume>
                <fpage>483</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21229316</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.seidner.1998.188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Seidner</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alvarez</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yeh</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O'Driscoll</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Klepper</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stump</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spinner</surname>
                    <given-names>NB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birnbaum</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier.</article-title>
                <source>Nat Genet</source>
                <volume>18</volume>
                <fpage>188</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">9462754</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.suls.2008.1831">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dedeken</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goffin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Esch</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dupont</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassiman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kempfle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuttke</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Afawi</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandenberghe</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korczyn</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekstein</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kivity</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryvlin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claes</surname>
                    <given-names>LR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deprez</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vargas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Dyck</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del-Favero</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Laere</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Paesschen</surname>
                    <given-names>W</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.</article-title>
                <source>Brain.</source>
                <volume>131</volume>
                <fpage>1831</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">18577546</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.urbizu.2010.110">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Urbizu</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuenca-Le&#x000f3;n</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raspall-Chaure</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gratac&#x000f2;s</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conill</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redecillas</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roig-Quilis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Macaya</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Paroxysmal exercise-induced dyskinesia, writer's cramp, migraine with aura and absence epilepsy in twin brothers with a novel SLC2A1 missense mutation.</article-title>
                <source>J Neurol Sci</source>
                <volume>295</volume>
                <fpage>110</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">20621801</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.vermeer.2007.380">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vermeer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koolen</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Visser</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brackel</surname>
                    <given-names>HJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Burgt</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Leeuw</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Willemsen</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sistermans</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pfundt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>BB</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>A novel microdeletion in 1(p34.2p34.3), involving the SLC2A1 (GLUT1) gene, and severe delayed development.</article-title>
                <source>Dev Med Child Neurol</source>
                <volume>49</volume>
                <fpage>380</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17489814</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.von_moers.2002.941">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>von Moers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenke</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huppke</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>EEG features of glut-1 deficiency syndrome.</article-title>
                <source>Epilepsia.</source>
                <volume>43</volume>
                <fpage>941</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12181017</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.wang.2001a.s125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korenke</surname>
                    <given-names>CG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Von Moers</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuang</surname>
                    <given-names>KY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kranz-Eble</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbarg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanefeld</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2001a</year>
                <article-title>Glut-1 deficiency syndrome: autosomal dominant transmission of the R126H missense mutation.</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>S125</fpage>
              </element-citation>
            </ref>
            <ref id="glut1.REF.wang.2001b.s124">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>Y-Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hinton</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Anolik</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kranz-Eble</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstadt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2001b</year>
                <article-title>GLUT1 deficiency syndrome: R333W genotype and paternal mosaicism.</article-title>
                <source>Ann Neurol</source>
                <volume>50</volume>
                <fpage>S124</fpage>
              </element-citation>
            </ref>
            <ref id="glut1.REF.wang.2000.224">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kranz-Eble</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Mutational analysis of GLUT1 (SLC2A1) in Glut-1 deficiency syndrome.</article-title>
                <source>Hum Mutat</source>
                <volume>16</volume>
                <fpage>224</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">10980529</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.wang.2005.111">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhung</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.</article-title>
                <source>Ann Neurol</source>
                <volume>57</volume>
                <fpage>111</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">15622525</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.wang.2006.1169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cheng</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yoo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noebels</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A mouse model for Glut-1 haploinsufficiency.</article-title>
                <source>Hum Mol Genet.</source>
                <volume>15</volume>
                <fpage>1169</fpage>
                <lpage>79</lpage>
                <pub-id pub-id-type="pmid">16497725</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.wang.2008.538">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fujii</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pascual</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Functional studies of the T295M mutation Causing Glut1 Deficiency:Glucose efflux preferentially affected by T295M.</article-title>
                <source>Pediatr Res</source>
                <volume>64</volume>
                <fpage>538</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">18614966</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.weber.2011.959">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>YG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kempfle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotschet</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000fc;le</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuttke</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liebrich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ludolph</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Paesschen</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sch&#x000f6;ls</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auburger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Paroxysmal choreoathetosis/spasticity (DYT9) is caused by a GLUT1 defect.</article-title>
                <source>Neurology.</source>
                <volume>77</volume>
                <fpage>959</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">21832227</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.weber.2008.2157">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Weber</surname>
                    <given-names>YG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storch</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wuttke</surname>
                    <given-names>TV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brockmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kempfle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maljevic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margari</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kamm</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schneider</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pekrun</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roebling</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seebohm</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kraft</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blazevic</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Salvo-Vargas</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fauler</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mottaghy</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;nchau</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edwards</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Presicci</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Margari</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gasser</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lang</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhatia</surname>
                    <given-names>KP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lehmann-Horn</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lerche</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak.</article-title>
                <source>J Clin Invest.</source>
                <volume>118</volume>
                <fpage>2157</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">18451999</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.wong.2005.775">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wong</surname>
                    <given-names>HY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chu</surname>
                    <given-names>TS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fung</surname>
                    <given-names>PK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fok</surname>
                    <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ho</surname>
                    <given-names>YY</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Sodium valproate inhibits glucose transport and exacerbates Glut1-deficiency in vitro.</article-title>
                <source>J Cell Biochem.</source>
                <volume>96</volume>
                <fpage>775</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">16149077</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.yang.2011.996">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Engelstad</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bagay</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wei</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotstein</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aggarwal</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ma</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>WK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vivo</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Glut1 deficiency syndrome and erythrocyte glucose uptake assay</article-title>
                <source>Ann Neurol.</source>
                <volume>70</volume>
                <fpage>996</fpage>
                <lpage>1005</lpage>
                <pub-id pub-id-type="pmid">22190371</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.zorzi.2008.146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zorzi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castellotti</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zibordi</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gellera</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nardocci</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Paroxysmal movement disorders in GLUT1 deficiency syndrome.</article-title>
                <source>Neurology</source>
                <volume>71</volume>
                <fpage>146</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18606970</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="glut1.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="glut1.Suggested_Reading.reflist0">
            <ref id="glut1.REF.de_vivo.2008">
              <mixed-citation publication-type="book">De Vivo DC, Wang D, Pascual JM. Disorders of glucose transport. In: Rosenberg R, DiMauro S, Paulson HL, Pt&#x000e1;&#x0010d;ek L, Nestler E, eds. <italic toggle="yes">The Molecular and Genetic Basis of Neurologic and Psychiatric Disease</italic>. 4 ed. Chap 59. Philadelphia, PA: Butterworth-Heinemann; 2008:653-62</mixed-citation>
            </ref>
            <ref id="glut1.REF.gaspard.2011.300">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gaspard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilain</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Bogaert</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>"Benign" myoclonic epilepsy of infancy as the initial presentation of glucose transporter-1 deficiency.</article-title>
                <source>Epileptic Disord.</source>
                <year>2011</year>
                <volume>13</volume>
                <fpage>300</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">21865127</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.mullen.2011.1152">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Della Giustina</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arsov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Damiano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lawrence</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guerrini</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy.</article-title>
                <source>Arch Neurol.</source>
                <year>2011</year>
                <volume>68</volume>
                <fpage>1152</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">21555602</pub-id>
              </element-citation>
            </ref>
            <ref id="glut1.REF.mullen.2010.432">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mullen</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suls</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berkovic</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Scheffer</surname>
                    <given-names>IE</given-names>
                  </name>
                </person-group>
                <article-title>Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.</article-title>
                <source>Neurology.</source>
                <year>2010</year>
                <volume>75</volume>
                <fpage>432</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">20574033</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="glut1.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="glut1.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>22 January 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 August 2012 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 July 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>9 September 2008 (cd) Revision: mutations in SLC2A1 identified in some families/individuals with paroxysmal exercise-induced dyskinesia and epilepsy; edits to Genetically Related Disorders</p>
            </list-item>
            <list-item>
              <p>4 April 2007 (jp) Revision: deletion/duplication analysis clinically available</p>
            </list-item>
            <list-item>
              <p>6 December 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>4 April 2005 (jp) Revision: sequence analysis clinically available</p>
            </list-item>
            <list-item>
              <p>16 July 2004 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>9 August 2002 (jp) Author revisions</p>
            </list-item>
            <list-item>
              <p>30 July 2002 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>21 February 2002 (jp) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
